This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Epidemiology

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

epidemiology

Hereditary haemochromatosis is a condition seen throughout the world (1).

  • it is the most common single gene disorder in North European populations, especially Nordic or Celtic ancestry, in which it occurs with a prevalence of approximately 1 per 220-250 individuals (1,2)

  • a systemic review has reported that 0.4% of people of northern European descent have the genetic mutation that increases the risk of developing haemochromatosis
    • however the clinical penetrance of the mutation is much lower than the genetic prevalence.

Around 80% of cases display homozygous C282Ymutation of the HFE gene on chromosome 6.

  • homozygous C282Ymutation
    • affects nearly 1 in 250 white people
    • estimated prevalence among non white population is low – 0.00004- 0.1%

  • in population screening studies, 25-50% of the homozygotes are found to be asymptomatic

Compound heterozygosity for C282Y/H63D is present in 4-7% of patients while homozyguous H63D is seen in around 1% (1)

Around 5% are non HFE mutations (1).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.